Lipoproteins and ImmunoMetabolism

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

May 31, 2023

Study Completion Date

December 31, 2025

Conditions
ObesityMetabolic SyndromeMetabolism DisorderInflammationImmune System and Related Disorders
Interventions
DIETARY_SUPPLEMENT

Lipid Emulsion

The oral lipid emulsions will contain water, sucrose, emulsifier, flavouring, and the corresponding fat (50 g/m2 of body surface area): milk cream (SFA) or refined olive oil (MUFA) with or without a dose of omega-3 PUFA, which will consist of 920 mg of EPA and 760 mg of DHA.

Trial Locations (1)

41009

University of Seville, Seville

All Listed Sponsors
collaborator

Spanish National Research Council

OTHER_GOV

lead

University of Seville

OTHER